1EOL | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | BBS, CPI, DOA, NLE | enzyme |
| ||||||||||||
related structures | by homologous chain: 1EOJ, 1THP, 1THS | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures., Slon-Usakiewicz JJ, Sivaraman J, Li Y, Cygler M, Konishi Y, Biochemistry 2000 Mar 7;39(9):2384-91. PMID:10694407 |
Data retrieval |
![]() |
View 1EOL in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |